RPTH Journal/LinekdIn
Sep 11, 2025, 14:25
Thrombin Generation Assays to Assess COC-Associated Procoagulant Alterations
RPTH Journal shared on LinkedIn:
”Combined oral contraception (COC) alters hemostasis in ways standard labs may underestimate.
Thrombin generation assays with anti-PS and anti–TFPI antibodies revealed a marked reduction in anticoagulant activity after just 3 months of COC use.”
Raed the full article in RPTH.
Article: The impact of protein S and tissue factor pathway inhibitor on coagulation, assessed with thrombin generation, in women starting combined oral contraceptives
Authors: Jesper Strandberg, Jette Nybo, Inger Lise Gade, Søren Risom Kristensen
Stay updated on all scientific advances in the field of thrombosis with Hemostasis Today.
-
Dec 20, 2025, 18:30Kate Scrivener on Cochrane Review: 2025 Ends With a Big Milestone!
-
Dec 20, 2025, 18:19A CT-Based Clinical Overview from Muhammad Abubakar: Stroke and Intracranial Hemorrhages
-
Dec 20, 2025, 18:15Shekher Bose on AstraZeneca’s Voluntary Withdrawal of Andexxa
-
Dec 20, 2025, 17:10Mina Adel Nagi on the Future of ESR Testing with HORIBA’s CoRA Technology
-
Dec 20, 2025, 17:02Osman Farhan on Participation in 2nd TIF Workshop for Thalassemia and Sickle Cell Warriors
-
Dec 20, 2025, 16:50Geert Verheyden on Advancing Stroke Rehabilitation Through Collaboration and Innovation
-
Dec 20, 2025, 16:26Dirk Sibbing on Antithrombotic Drugs for ACS in Women
-
Dec 20, 2025, 16:13Akshat Jain Explains VWF/FVIII Prophylaxis in Children Under 6
-
Dec 20, 2025, 15:49Manuel Requena Shares The Results of the RESISTANT International Registry